# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Article 106

Extent: E+W+S+N.I.

Each Member State shall set up and maintain a national medicines web-portal which shall be linked to the European medicines web-portal established in accordance with Article 26 of Regulation (EC) No 726/2004. By means of the national medicines web-portals, the Member States shall make publicly available at least the following:
(a) public assessment reports, together with a summary thereof;
(b) summaries of product characteristics and package leaflets;
(c) summaries of risk management plans for medicinal products authorised in accordance with this Directive;
(d) the list of medicinal products referred to in Article 23 of Regulation (EC) No 726/2004;
(e) information on the different ways of reporting suspected adverse reactions to medicinal products to national competent authorities by healthcare professionals and patients, including the web-based structured forms referred to in Article 25 of Regulation (EC) No 726/2004.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/article/106 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/article-106
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.